Insmed, Inc. (INSM)
121.55
+3.21
(+2.71%)
USD |
NASDAQ |
Sep 24, 16:00
122.89
+1.34
(+1.10%)
After-Hours: 04:25
Insmed Gross Profit (Annual) : 477.48M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 477.48M |
| December 31, 2024 | 272.91M |
| December 31, 2023 | 234.58M |
| December 31, 2022 | 185.18M |
| December 31, 2021 | 139.26M |
| December 31, 2020 | 119.54M |
| December 31, 2019 | 107.26M |
| December 31, 2018 | 2.586M |
| December 31, 2017 | -2.901M |
| December 31, 2016 | -2.438M |
| December 31, 2015 | -1.982M |
| December 31, 2014 | -1.073M |
| December 31, 2013 | 0.00 |
| December 31, 2012 | -0.561M |
| Date | Value |
|---|---|
| December 31, 2011 | 4.074M |
| December 31, 2010 | 6.867M |
| December 31, 2009 | 9.666M |
| December 31, 2008 | 10.66M |
| December 31, 2007 | 6.953M |
| December 31, 2006 | -3.868M |
| December 31, 2005 | -12.77M |
| December 31, 2004 | 0.103M |
| December 31, 2003 | 0.054M |
| December 31, 2002 | 1.609M |
| December 31, 2001 | -1.246M |
| December 31, 2000 | 0.00 |
| December 31, 1999 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 971.62M |
| Biogen, Inc. | 6.454B |
| Gilead Sciences, Inc. | 23.22B |
| Agios Pharmaceuticals, Inc. | 42.51M |
| Arcutis Biotherapeutics, Inc. | 339.38M |